In order to monitor progress towards the United Nations Sustainable Development Goals 2030 target to combat viral hepatitis, this report provides data on hepatitis B and C prevention, incidence, diagnosis, treatment, cure/viral suppression, and mortality in European Union/European Economic Area (EU/EEA) countries with data collected in 2019.

The aim of this document is to provide a summary of the available scientific evidence on the risk of SARS-CoV-2 transmission to susceptible contacts from infected individuals with documented previous infection or vaccination.

The aim of this report is to share the challenges countries are facing with the rollout of the COVID-19 vaccine deployment process. It also aims to share lessons learned and good practice that countries have put in place to mitigate the challenges.

This document presents a coherent, yet non-prescriptive framework for tuning COVID-19 response measures in the European Union and European Economic Area (EU/EEA). Its aim is to ensure efficiency and encourage public trust and compliance, while continuing to protect the health of European citizens.

This document outlines the public health considerations for the use of self-tests to detect SARS-CoV-2 by public health authorities in the European Union/European Economic Area (EU/EEA). Only rapid antigen detection tests (RADTs) for self-testing for direct detection of SARS-CoV-2 virus particles in infectious individuals are considered within this document.

This document provides guidance based on scientific evidence regarding quarantine and testing of travellers in EU/EEA countries in the context of the emergence of SARS-CoV-2 variants of concern (VOCs).

This technical report reviews the evidence that has been accumulated since the emergence of COVID-19, in addition to what has existed on this topic prior to the pandemic, and updates the ECDC opinion on the suitability of using face masks in the community published on 9 April 2020.

This document aims to provide guidance to EU/EEA healthcare facilities and healthcare providers on infection prevention and control (IPC) measures for the management of suspected and confirmed cases of COVID-19 infection in healthcare settings, including long-term care facilities. It also offers guidance on the management of specimens at laboratories in the EU/EEA.